Non-Insulin-Dependent Diabetes Mellitus Clinical Trial
Official title:
Effect of Dietary Fiber on Glucose, Lipid, and Mineral Metabolism in Patients With Non Insulin Dependent Diabetes Mellitus
Effect of Dietary Fiber on glucose, lipid, and mineral metabolism in patients with non insulin dependent diabetes mellitus.
| Status | Completed |
| Enrollment | 13 |
| Est. completion date | December 1995 |
| Est. primary completion date | December 1995 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 35 Years to 80 Years |
| Eligibility |
Inclusion Criteria: - NIDDM - age 35 to 80 years - stable oral hypoglycemic treatment for at least one month - fasting triglycerides < 500 mg/dl Exclusion Criteria: - insulin dependent NIDDM - insulin dependent diabetes - hepatic disease - significant hepatic dysfunction - signifiacnt renal dysfunction - presence of significant hematological, neurological, cardiovascular or gastrointestinal disorder, unless stable for past 6 months, - serious intercurrent illness or anticipated major surgery - female pregnant or likely to become pregnant - chronic drug abuse, alcoholism or psychaitric disorder within the past 2 years - treated with beta adrenergic blockers - on lipid lowering drugs |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| University of Texas Southwestern Medical Center |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | glucose and lipid metabolism | Baseline and during the last 5 days of each 6 week dietary phase | No | |
| Secondary | calcium isotope absorption in the gastrointestinal tract, stool mineral content, 24 h urinary mineral concentration, and serum chemistry including mineral concentration. | Baseline and during the last 5 days of each 6 week dietary phase | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00231387 -
Rosiglitazone And Plaque Study for Type 2 Diabetes Mellitus
|
Phase 3 | |
| Completed |
NCT00318656 -
24-Hour Glycemia: Rosiglitazone Versus Glimepiride In Type 2 Diabetes
|
Phase 4 | |
| Terminated |
NCT01582282 -
Study of Metamucil on Blood Glucose and HbA1c in Type II NIDDM Subjects
|
Phase 4 | |
| Not yet recruiting |
NCT06401733 -
Intensive Aerobic and Resistance Exercise Program (IAREP)
|
N/A | |
| Completed |
NCT02722499 -
Financial Incentives Telephone Education and Skills Trial in African Americans With Diabetes (FITEST)
|
N/A | |
| Completed |
NCT01472328 -
Effects of HBO Therapy on Muscular Insulin Resistence in Type 2 Diabetes
|
N/A | |
| Completed |
NCT00291356 -
GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients
|
Phase 2 | |
| Completed |
NCT00269061 -
Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or Insulin
|
Phase 1 | |
| Completed |
NCT00359112 -
AVANDAMET Versus Metformin And Sulphonylurea In People With Poorly Controlled Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT00156897 -
Efficacy and Safety of ATL-962 in Obese Diabetics
|
Phase 2 |